A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

Weeks, KL; Kiriazis, H; Wadley, Glenn; Masterman, EI; Sergienko, NM; Raaijmakers, AJA; Trewin, Adam; Harmawan, CA; Yildiz, GS; Liu, Y; Drew, BG; Gregorevic, P; Delbridge, LMD; McMullen, JR; Bernardo, BC

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

https://hdl.handle.net/10779/DRO/DU:24654030

journal contribution

posted on 2025-09-09, 13:29 authored by KL Weeks, H Kiriazis, Glenn WadleyGlenn Wadley, EI Masterman, NM Sergienko, AJA Raaijmakers, Adam TrewinAdam Trewin, CA Harmawan, GS Yildiz, Y Liu, BG Drew, P Gregorevic, LMD Delbridge, JR McMullen, BC Bernardo

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1007/s00109-023-02397-2

Location

Berlin, Germany

Open access

No

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/37987775

Publication classification

C1 Refereed article in a scholarly journal

Journal

Journal of Molecular Medicine

Volume

102

Pagination

95-111

ISSN

0946-2716

eISSN

1432-1440

Publisher

Springer

Publication URL

http://dx.doi.org/10.1007/s00109-023-02397-2

Usage metrics

Keywords

Dehydrogenase Diabetes Diabetic cardiomyopathy Gene therapy Metabolism

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

History

Related Materials

Location

Open access

Language

Author URL

Publication classification

Journal

Volume

Pagination

ISSN

eISSN

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports